# Major Recall Alert: NRA-AMLODIPINE 5MG Recalled Due to Possible Contamination with Metoprolol Succinate Tablets
Consumers, take note! NORA PHARMA INC has issued an important recall for their NRA-AMLODIPINE 5MG medication. Affected lots have been found to contain Metoprolol Succinate prolonged–release 12.5 mg tablets, a mix-up that could pose serious health risks. Read on for crucial details about this recall, its implications, and what you need to do next to stay safe.
## Why This Recall is Important
Medication mix-ups can lead to unintended health complications, especially when prescribed drugs are switched with others that serve entirely different purposes. The NRA-AMLODIPINE 5MG is commonly used to treat high blood pressure (hypertension) or prevent chest pain (angina). However, Metoprolol Succinate prolonged–release 12.5 mg is a beta-blocker that lowers blood pressure differently and can significantly impact heart rate.
The unauthorized presence of Metoprolol in this product could endanger patients, particularly those:
- With certain heart conditions that require stable medication.
- Sensitive to Metoprolol or who have adverse reactions to beta-blockers.
- Who incorrectly administered the mix-up, leading to unexpected side effects or interactions.
This recall is a serious alert for patients currently taking NRA-AMLODIPINE 5MG and healthcare providers who prescribe it.
## Details of the Recall
Here’s everything you need to know about this issue:
- **Category**: Medications sold in Canada
- **Brand**: NORA PHARMA INC
- **Product**: NRA-AMLODIPINE 5MG tablets
- **Recall Reason**: Affected lots may contain Metoprolol Succinate prolonged–release 12.5 mg tablets instead.
- **Date Announced**: October 3, 2023
- **Health Risks**: Potential side effects include low heart rate (bradycardia), irregular heartbeat, fatigue, dizziness, or other cardiovascular complications.
For the official announcement, visit the recall page [here](https://recalls-rappels.canada.ca/en/alert-recall/nra-amlodipine-5mg-affected-lot-may-contain-tablets-metoprolol-succinate-prolonged).
## What You Should Do
If you have recently purchased NORA PHARMA INC’s NRA-AMLODIPINE 5MG, follow these steps immediately:
- **Check the Packaging**: Stop using the product and confirm if your purchased lot is affected by referring to the recall notice.
- **Contact Your Pharmacist or Doctor**: Inform your healthcare provider immediately for instructions, especially if you suspect you’ve taken the wrong medication.
- **Dispose of Recalled Products Properly**: Follow local guidelines for safe medication disposal to ensure no one else is harmed.
- **Report Unexpected Side Effects**: If you’ve experienced adverse reactions, report it directly to Health Canada's MedEffect Adverse Reaction Reporting program.
Taking prompt action is essential to prevent any potential health complications from this recall.
## Stay Safe – Get Instant Recall Alerts
Medication recalls can happen at any time, and staying informed can save you from serious health risks. Don’t miss critical updates about product recalls in Canada by downloading our free recall tracking app today! With real-time notifications, you’ll always be the first to know about important recalls that impact your health and safety.
[Download the Recall Alert App Now!](#)
**Stay informed. Stay prepared. Stay safe.** For more information about this recall and others like it, visit Health Canada’s official recall page [here](https://recalls-rappels.canada.ca/en/alert-recall/nra-amlodipine-5mg-affected-lot-may-contain-tablets-metoprolol-succinate-prolonged).